Expansion of TAVR into Low-Risk Patients and Who to Consider for SAVR

Expansion of TAVR into Low-Risk Patients and Who to Consider for SAVR

Abstract Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of severe aortic stenosis (AS) over the last decade. The results of the Placement of Aortic Transcatheter Valves (PARTNER) 3 and Evolut Low Risk trials demonstrated the safety and efficacy of TAVR in low-surgical...

Full description

Bibliographic Details
Main Authors: Kunal V. Patel, Wally Omar, Pedro Engel Gonzalez, Michael E. Jessen, Lynn Huffman, Dharam J. Kumbhani, Anthony A. Bavry
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-09-01
Series:Cardiology and Therapy
Subjects:
Aortic stenosis
Low risk
SAVR
TAVR
Online Access:https://doi.org/10.1007/s40119-020-00198-z

Internet

https://doi.org/10.1007/s40119-020-00198-z

Similar Items